跳至主要内容
临床试验/JPRN-UMIN000009983
JPRN-UMIN000009983已完成未知

Feasibility analysis of the recombinant human thrombomodulin (rTM) for disseminated intravascular coagulation in the perioperative period of Hepato-Biliary-Pancreatic Surgery - Feasibility analysis of the recombinant human thrombomodulin (rTM) for disseminated intravascular coagulation in the perioperative period of Hepato-Biliary-Pancreatic Surgery

Tohoku University Hospital0 个研究点目标入组 20 人开始时间: 2013年2月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. severe bleeding (intracranial bleeding, GI bleeding, Lung bleeding) 2. Patients are likely to cause life-threatening bleeding 3. Patients with a history of cerebrovascular bleeding within one year of 4. not long after the surgery of the central nervous system and trauma 5. Patients with a history of hypersensitivity to heparin or unfractionated protein preparation 6.Pregnant or supposed to be pregnant patient 7. Early death is estimated as well as restored the DIC, the patient seems to be difficult to obtain the data and ensure the efficacy and safety of the investigational drug administration period sufficient 8. Patients were deemed inappropriate investigator

研究者

相似试验

Feasibility analysis of the recombinant human... | 临床试验